Thomas Civik, Director at Repare Therapeutics Inc. (RPTX), bought 7,500 shares at $28.08 ($211K) on 2021-11-16, disclosed to the SEC on 2021-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.